Recruiting JAB-2485 Activity in Adult Patients With Advanced Solid Tumors NCT05490472 Conditions ARID1A Gene Mutation, Breast Diseases, Breast Neoplasms, +17 more Locations Henry Ford Health System — Detroit, Michigan, United States Washington University — St Louis, Missouri, United States Mary Crowley Cancer Research — Dallas, Texas, United States University of Utah Huntsman Cancer Institute — Salt Lake City, Utah, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Avelumab and M1774 in ARID1A-mutated Endometrial Cancer NCT06518564 Conditions ARID1A Gene Mutation, Endometrial Cancer, Endometrial Neoplasms, +12 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States Brigham and Women's Hospital — Boston, Massachusetts, United States View Trial Details
Active, Not Recruiting A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer NCT05226507 Conditions ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more Locations Honor Health — Phoenix, Arizona, United States UC San Diego Health - Moores Cancer Center — La Jolla, California, United States University of Colorado Cancer Center — Aurora, Colorado, United States Yale Gynecologic Oncology — New Haven, Connecticut, United States View all 22 locations View more locations Show fewer locations Loading locations... View Trial Details
